Generative AI is transforming pharma’s slowest lane —regulatory affairs — into a fast track for life-saving treatments. Bringing a new drug to market is one of the most expensive and time-consuming ...

Gaining novel food regulatory approval is one of the main barriers behind getting many innovative foods, including cultivated meat and precision fermented products, to market. The process takes time ...

The European Commission’s new strategy for life sciences, released on Wednesday, outlines how the EU aims to boost its life sciences sector. One of the key pillars of this is fostering innovation. In ...

New SEC rules could reshape the crypto ETF landscape by speeding up approvals, reducing the shutdown backlog and giving issuers a clearer and faster path to market. The SEC introduced new ...